Response of tic and obsessive-compulsive symptoms to striosomal dopaminergic modulation in tic-related OCD: an open-label pilot study
Objectives This study investigated the therapeutic potential of striosomes in addressing ICSDs, focusing on the treatment response of tic and obsessive-compulsive (OC) symptoms in tic-related OCD (T-OCD) to a pharmacological intervention designed to enhance striosomal dopamine signaling through D1-type receptors (D1Rs). Methods Ten participants with T-OCD [30% male; mean age, 40.5 years (SD 20.1); mean age at onset, 9.2 years (SD 4.1)] received L-DOPA/carbidopa (50 mg) plus chlorpromazine-phenolphthalinate (5 mg), with doses increased stepwise to three times daily over 8 weeks, then maintained for 1 year. We used the Yale Global Tic Severity Scale (YGTSS) and the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) for clinical assessments. For statistical analyses, we used repeated-measures ANOVA with Dunnett’s post hoc tests and calculated partial eta squared (η 2 ) to report effect sizes. Results The study cohort showed significant, sustained improvements in both tics and OCD symptoms. At one-year follow-up, Total Tic Severity Scale scores on the YGTSS decreased by 73.3% ( n = 10; mean difference, −11.0; 95% CI, −13.99 to −8.04; p = 0.0025; η 2 = 0.715) compared with the baseline. In parallel, Y-BOCS scores decreased by 85.1% ( n = 10; mean difference, −13.10; 95% CI, −17.71 to −8.49; p = 0.0004; η 2 = 0.639). No adverse effects were reported during this one-year study. Conclusion Pharmacologic modulation of striosomal D 1 R signaling could provide significant, durable benefits for patients with T-OCD. Given its efficacy and safety in reducing both tic and OC symptoms in T-OCD, striosomes may serve as a promising therapeutic target for ICSDs. These findings warrant further investigation through larger, randomized, and placebo-controlled clinical trials.
Authors
- Hideki Shimazu (ORCID: https://orcid.org/0000-0002-8507-5938)
- Shinichi Matsumoto (ORCID: https://orcid.org/0000-0002-6755-8549)
- Satoshi Goto (ORCID: https://orcid.org/0000-0002-8238-5762)
Institutions
- Mukogawa Women's University (JP)
- Osaka Neurological Institute (JP)
- Tokushima University (JP)
Publication Details
- Journal
- Frontiers in Human Neuroscience
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fnhum.2026.2018962
- Primary Topic
- Obsessive-Compulsive Spectrum Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00